EPIGENALYTICS
DEAD

Serial Number

97163732

Owner

LCR BIOLOGICALS, LLC

Filing Date

Dec 9, 2021

Add to watchlist:

No watchlists yet
View on USPTO

EPIGENALYTICS Trademark

Serial Number: 97163732

EPIGENALYTICS is a trademark filed by LCR BIOLOGICALS, LLC on December 9, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

LCR BIOLOGICALS, LLC (2 trademarks)

Morristown, NJ 07960

Entity Type: 16

Trademark Details

Filing Date

December 9, 2021

Registration Date

Not Registered

Goods & Services

Testing kits comprised of medical diagnostic reagents and assays for testing for environmental and chemical toxins; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, Autoimmune Diseases, Chronic Fatigue, Chronic Fatigue Syndrome, Myalgic Encephalitis or ME, and Fibromyalgia, Complex Chronic Illness, Gut Dysbiosis and Microbiome Disturbance, Inflammatory Bowel Disorders, Mold Illness, Mycotoxicosis, Degenerative Neurological Disorders, MS, ALS, MND, PD, Alzheimer's, Lewy Body Dementia, Neuropsychiatric Illnesses, PANDAS, PANS, Acute and Chronic Lyme Disease, genetic diseases, chronic illnesses, cancer, "aging" and other diseases; Diagnostic kits comprised of medical diagnostic reagents and assays for use in the fields of genetics, epigenetics and toxicology; Diagnostic kits comprised of medical diagnostic reagents and assays for detecting substances having the potential for or affecting genetic expression, epigenetic expression; Diagnostic kits comprised of medical diagnostic reagents and assays for testing DNA and RNA and mitochondria

Medical diagnostic testing and reporting services; Medical analysis for the diagnosis and treatment of persons

Blood collection kits comprised of blood sample collection tubes and vials; medical sample tubes and vials for collecting blood samples; Biosensors for use in environmental safety and testing; biosensors for use in disease detection, namely, Autoimmune Diseases, Chronic Fatigue Chronic Fatigue Syndrome, Myalgic Encephalitis or ME and Fibromyalgia, Complex Chronic Illness, Gut Dysbiosis and Microbiome Disturbance, Inflammatory Bowel Disorders, Mold Illness, Mycotoxicosis, Degenerative Neurological Disorders, MS, ALS, MND, PD, Alzheimer's, Lewy body dementia, Neuropsychiatric Illnesses, PANDAS, PANS, Acute and Chronic Lyme Disease, genetic diseases, chronic illnesses, cancer, "aging" and other diseases; biosensors for diagnostic use in the fields of genetics, epigenetics and toxicology; biosensors for detecting substances having the potential for or affecting genetic expression, epigenetic expression; biosensors for testing DNA and RNA and mitochondria; Medical apparatus and instrument for testing for environmental and chemical toxins; Medical apparatus and instrument for testing of bodily fluids for use in disease detection, namely, Autoimmune Diseases, Chronic Fatigue Chronic Fatigue Syndrome, Myalgic Encephalitis or ME and Fibromyalgia, Complex Chronic Illness, Gut Dysbiosis and Microbiome Disturbance, Inflammatory Bowel Disorders, Mold Illness, Mycotoxicosis, Degenerative Neurological Disorders, MS, ALS, MND, PD, Alzheimer's, Lewy Body Dementia, Neuropsychiatric Illnesses, PANDAS, PANS, Acute and Chronic Lyme Disease, genetic diseases, chronic illnesses, cancer, "aging" and other diseases; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of genetics, epigenetics and toxicology; medical apparatus and instrument for detecting substances having the potential for or affecting genetic expression, epigenetic expression; Medical diagnostic apparatus for testing DNA and RNA and mitochondria

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Apr 5, 2023 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Apr 5, 2023 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Apr 5, 2023 ABN2
WITHDRAWAL OF ATTORNEY GRANTED
Feb 23, 2023 WOAG
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Feb 23, 2023 WOAR
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 23, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 23, 2023 TCCA
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 23, 2023 COAR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 21, 2022 GNRN
NON-FINAL ACTION E-MAILED
Sep 21, 2022 GNRT
NON-FINAL ACTION WRITTEN
Sep 21, 2022 CNRT
ASSIGNED TO EXAMINER
Sep 18, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 14, 2021 NWOS
NEW APPLICATION ENTERED
Dec 13, 2021 NWAP